ArticleJournal of medicinal chemistry2025

Rationally Designed, Short-Acting RPE65 Inhibitors for Visual Cycle-Associated Retinopathies.

Marco Bassetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.